首页> 外文期刊>Environmental toxicology and chemistry >UPTAKE AND ELIMINATION OF PERFLUORINATED PHOSPHONIC ACIDS IN THE RAT
【24h】

UPTAKE AND ELIMINATION OF PERFLUORINATED PHOSPHONIC ACIDS IN THE RAT

机译:摄取和消除大鼠体内的全磷酸

获取原文
获取原文并翻译 | 示例
       

摘要

The mono- and di-substituted perfluorinated phosphonic acids (mono-PFPAs and di-PFPAs) are high production volume fluorinated surfactants. Mono-PFPAs have been observed in Canadian surface waters and wastewater treatment plant (WWTP) effluent. The first observation of the di-PFPAs in the environment is reported here, with the observation of the C6/C6 and C6/C8 di-PFPAs in the National Institute for Standards and Technology (NIST) WWTP sludge standard reference material (SRM) 2781. To characterize the risk associated with human exposure to the mono-PFPAs and di-PFPAs, we determined uptake and elimination parameters in the rat. After oral gavage all of the mono-PFPA and di-PFPA congeners were observed in the blood of the dosed animals. Half-lives after intraperitoneal dosing ranged from 0.96 ± 0.11 to 2.8 ± 0.5 days for the mono-PFPAs and 1.8 ± 0.1 to 9.3 ± 1.5 days for the di-PFPAs. These half-lives are of similar magnitude to those for perfluorooctane sulfonate (PFOS, 8 to 30 days in male rats) and perfluorooctanoate (PFOA, 6 days in male rats and 1 hour in female rats). Both PFOS and PFOA have human half-lives on the order of years, and so the mono-PFPAs and di-PFPAs may also have significant lifetimes in the human body. The analysis of paired whole blood and plasma samples demonstrated that the mono-PFPAs may bind to blood cells underestimating their concentration in plasma and sera samples. The biological fate of the mono-PFPAs and di-PFPAs determined here suggest there is the potential for human exposure and that if exposure does occur, they may be long-lived in the body.
机译:单和双取代的全氟膦酸(单-PFPA和双-PFPA)是高产量的氟化表面活性剂。在加拿大地表水和废水处理厂(WWTP)的废水中观察到了单PFPA。此处首次报告了对环境中di-PFPA的观察,并在美国国家标准技术研究院(NIST)WWTP污泥标准参考物质(SRM)2781中观察到了C6 / C6和C6 / C8 di-PFPA。为了表征与人类接触一元PFPA和二元PFPA相关的风险,我们确定了大鼠的摄取和消除参数。口服管饲后,在给药动物的血液中观察到所有单-PFPA和双-PFPA同系物。单PFPAs腹膜内给药后的半衰期为0.96±0.11至2.8±0.5天,双PFPAs的半衰期为1.8±0.1至9.3±1.5天。这些半衰期的大小与全氟辛烷磺酸盐(PFOS,雄性大鼠为8至30天)和全氟辛酸磺酸盐(PFOA,雄性大鼠为6天,雌性大鼠为1小时)相似。 PFOS和PFOA的人均半衰期均在数年左右,因此,单PFPA和di-PFPA在人体中的寿命也可能很长。对全血和血浆样品配对的分析表明,单PFPA可能与血细胞结合,从而低估了血浆和血清样品中的浓度。此处确定的一元-全氟辛烷磺酸和二元-全氟辛烷磺酸的生物命运表明,存在人类暴露的可能性,如果确实发生暴露,它们可能在体内长寿。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号